Your account is not claimed yet. You can sign up with ORCID to claim your account.

Johannes Ridinger

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Replacement Therapy

Coronary Artery Bypass

High Throughput

Histone Deacetylase

Top Venues

Chembiochem : a European journal of chemical biology

Methods in molecular biology (Clifton, N.J.)

German Cancer Research Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

German Cancer Research Center

Germany

Postdoctoral Researcher

Publications

Daniel Herp, Johannes Ridinger, Dina Robaa, Stephen A Shinsky, Karin Schmidtkunz, Talha Z Yesiloglu, Theresa Bayer, Raphael R Steimbach, Corey J Herbst-Gervasoni, Annika Merz, Christophe Romier, Peter Sehr, Nikolas Gunkel, Aubry K Miller, David W Christianson, Ina Oehme, Wolfgang Sippl, Manfred Jung
First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement. Chembiochem : a European journal of chemical biology 23 (14) (2022)
Salma Darwish, Tino Heimburg, Johannes Ridinger, Daniel Herp, Matthias Schmidt, Christophe Romier, Manfred Jung, Ina Oehme, Wolfgang Sippl
Synthesis, Biochemical, and Cellular Evaluation of HDAC6 Targeting Proteolysis Targeting Chimeras. Methods in molecular biology (Clifton, N.J.) 2589 (2022)
Michael Morgen, Raphael R Steimbach, Magalie Géraldy, Lars Hellweg, Peter Sehr, Johannes Ridinger, Olaf Witt, Ina Oehme, Corey J Herbst-Gervasoni, Jeremy D Osko, Nicholas J Porter, David W Christianson, Nikolas Gunkel, Aubry K Miller
Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors. ChemMedChem 15 (13) (2020)